Nearly one in nine adults worldwide now live with diabetes, totaling 589 million people, according to the International Diabetes Federation’s 2025 Diabetes Atlas.
Around 252 million of those people remain undiagnosed. Many discover the condition only after complications begin.
Rising Claims and Earlier Impact in the UAE
Data from Zurich International Life’s The Value of Life report shows how this health burden manifests in the UAE. Heart attacks and strokes represent 41 percent of death claims and account for 39 percent of critical illness claims, according to Urgent.
These serious conditions arrive earlier in life. The youngest recorded life cover claim was at age 25. The average age for heart attack and stroke claims reached 52. Critical illness claims averaged age 50. Among women, deaths from heart attack and stroke are four times higher than in 2020.
This means diabetes-linked illnesses often strike people during their peak working years, when careers, children, and aging parents depend on them most.
Economic Burden and Medication Costs in the United States
In the United States, diabetes stands as the most expensive chronic disease, according to the Centers for Disease Control and Prevention. Total diabetes costs exceeded $400 billion in 2022.

A study published in Diabetes Research and Clinical Practice tracked insurance claims between 2009 and 2018. Researchers found that type 1 diabetes carried the greatest total and out-of-pocket costs at $25,652 and $2,037, respectively, in 2018.
Type 2 diabetes followed closely in costs. By comparison, people without diabetes paid an average of $14,220 in total expenses and $1,122 out of pocket.
While total costs climbed across all groups from 2009 to 2018, only patients with type 1 diabetes experienced growth in out-of-pocket expenses.
“If the trends we observed continue, people with type 1 diabetes will be facing increasingly unaffordable out-of-pocket costs,” said Evan Reynolds, lead statistician for the NeuroNetwork for Emerging Therapies at Michigan Medicine and first author of the study reported by Umich.
Rising medication prices drive this trend. Antihyperglycemic drugs like insulin increased steadily in price for both type 1 and type 2 diabetes.
“Studies show that the more a patient pays out-of-pocket, the less likely they are to stick with their medication long term, which poses a serious risk to their health,” Reynolds said.
“Financial toxicity is when medical expenses begin to negatively affect all areas of a patient’s life, impacting both their physical and mental health,” Reynolds said.
“Diabetes care providers should be actively screening for the side effects of these costs, looking for signs of depression or anxiety,” Reynolds said.
Mitigating Risk Through Screening and Policy
Much of the risk associated with diabetes can be mitigated. Regular screening is essential, particularly for people with excess weight, high blood pressure, or a family history of the condition.
Employers can also help by providing workplace health checks, time off for medical appointments, and practical well-being support so employees can manage chronic conditions while working.
Financial planning remains vital because serious illnesses disrupt incomes and incur expenses not covered by health insurance, including home modifications and ongoing care. Zurich processes three out of five critical illness claims while the policyholder is still alive.
“We need to enact policies that will either reduce or stabilize out-of-pocket costs and encourage people to properly treat their diabetes,” Reynolds said.
“With medications coming out on top in cost and utilization, lowering insulin prices is imperative right now,” Reynolds said.